Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participation

Authors

Tim Luckett, University of SydneyFollow
Jane Phillips, Universty of Western Sydney, University of Technology Sydney
Nicholas Lintzeris, South East Sydney & Illawarra Area Health Service
David J. Allsop, University of Sydney
J Lee, University of New South Wales
Nadia Solowij, University of WollongongFollow
Jennifer H. Martin, University of Newcastle
L Lam, The Hong Kong Polytechnic University
R Aggarwal, Liverpool Hospital
Nikki McCaffrey, Flinders University
David C. Currow, Flinders University, Cancer Institute New South WalesFollow
R Chye, St Vincent's Hospital
Melanie Lovell, Hammond Care
Iain Prof Iain McGregor, University of SydneyFollow
Meera Agar, Braeside Hospital, Sydney South West Area Health Service, University of New South Wales

RIS ID

110462

Publication Details

Luckett, T., Phillips, J., Lintzeris, N., Allsop, D., Lee, J., Solowij, N., Martin, J., Lam, L., Aggarwal, R., McCaffrey, N., Currow, D., Chye, R., Lovell, M., Prof Iain McGregor, I. & Agar, M. (2016). Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participation. Internal Medicine Journal, 46 (11), 1269-1275.

Abstract

Australian clinical trials are planned to evaluate medicinal cannabis in a range of clinical contexts. Aims: To explore the preferences, attitudes and beliefs of patients eligible and willing to consider participation in a clinical trial of medicinal cannabis for poor appetite and appetite-related symptoms from advanced cancer.